FATE
Price
$1.16
Change
-$0.01 (-0.85%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
134.12M
35 days until earnings call
KPTI
Price
$4.54
Change
-$0.12 (-2.58%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
40.18M
Interact to see
Advertisement

FATE vs KPTI

Header iconFATE vs KPTI Comparison
Open Charts FATE vs KPTIBanner chart's image
Fate Therapeutics
Price$1.16
Change-$0.01 (-0.85%)
Volume$31.16K
Capitalization134.12M
Karyopharm Therapeutics
Price$4.54
Change-$0.12 (-2.58%)
Volume$200
Capitalization40.18M
FATE vs KPTI Comparison Chart in %
Loading...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KPTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FATE vs. KPTI commentary
Jun 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FATE is a Buy and KPTI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 25, 2025
Stock price -- (FATE: $1.17 vs. KPTI: $4.65)
Brand notoriety: FATE and KPTI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FATE: 66% vs. KPTI: 61%
Market capitalization -- FATE: $134.12M vs. KPTI: $40.18M
FATE [@Biotechnology] is valued at $134.12M. KPTI’s [@Biotechnology] market capitalization is $40.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FATE’s FA Score shows that 0 FA rating(s) are green whileKPTI’s FA Score has 0 green FA rating(s).

  • FATE’s FA Score: 0 green, 5 red.
  • KPTI’s FA Score: 0 green, 5 red.
According to our system of comparison, FATE is a better buy in the long-term than KPTI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FATE’s TA Score shows that 3 TA indicator(s) are bullish while KPTI’s TA Score has 5 bullish TA indicator(s).

  • FATE’s TA Score: 3 bullish, 6 bearish.
  • KPTI’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, KPTI is a better buy in the short-term than FATE.

Price Growth

FATE (@Biotechnology) experienced а -2.50% price change this week, while KPTI (@Biotechnology) price change was +6.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.95%. For the same industry, the average monthly price growth was +32.23%, and the average quarterly price growth was +16.56%.

Reported Earning Dates

FATE is expected to report earnings on Jul 30, 2025.

KPTI is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+1.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FATE($134M) has a higher market cap than KPTI($40.2M). FATE YTD gains are higher at: -29.091 vs. KPTI (-54.162). KPTI has higher annual earnings (EBITDA): -19.64M vs. FATE (-168.28M). FATE has more cash in the bank: 240M vs. KPTI (69.9M). FATE has less debt than KPTI: FATE (83.3M) vs KPTI (187M). KPTI has higher revenues than FATE: KPTI (142M) vs FATE (13.3M).
FATEKPTIFATE / KPTI
Capitalization134M40.2M333%
EBITDA-168.28M-19.64M857%
Gain YTD-29.091-54.16254%
P/E RatioN/AN/A-
Revenue13.3M142M9%
Total Cash240M69.9M343%
Total Debt83.3M187M45%
FUNDAMENTALS RATINGS
FATE vs KPTI: Fundamental Ratings
FATE
KPTI
OUTLOOK RATING
1..100
6954
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6291
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FATE's Valuation (50) in the Biotechnology industry is in the same range as KPTI (50). This means that FATE’s stock grew similarly to KPTI’s over the last 12 months.

FATE's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as KPTI (100). This means that FATE’s stock grew similarly to KPTI’s over the last 12 months.

FATE's SMR Rating (100) in the Biotechnology industry is in the same range as KPTI (100). This means that FATE’s stock grew similarly to KPTI’s over the last 12 months.

FATE's Price Growth Rating (62) in the Biotechnology industry is in the same range as KPTI (91). This means that FATE’s stock grew similarly to KPTI’s over the last 12 months.

FATE's P/E Growth Rating (100) in the Biotechnology industry is in the same range as KPTI (100). This means that FATE’s stock grew similarly to KPTI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FATEKPTI
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 22 days ago
85%
Bullish Trend 10 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KPTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JOB0.210.01
+2.79%
GEE Group
CTS43.301.13
+2.68%
CTS Corp
CRH91.521.59
+1.77%
CRH Public Limited
MSB23.110.26
+1.14%
Mesabi Trust
VG16.720.18
+1.09%
Venture Global Inc

KPTI and

Correlation & Price change

A.I.dvisor indicates that over the last year, KPTI has been loosely correlated with MGNX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if KPTI jumps, then MGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KPTI
1D Price
Change %
KPTI100%
+7.39%
MGNX - KPTI
38%
Loosely correlated
+1.52%
ARRY - KPTI
35%
Loosely correlated
-13.80%
XNCR - KPTI
35%
Loosely correlated
-1.66%
NTLA - KPTI
35%
Loosely correlated
+3.68%
FATE - KPTI
35%
Loosely correlated
+2.63%
More